Mitsubishi UFJ Trust & Banking Corp
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1462160
TOKYO, M0
Position in VRTX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$86,834,364
+$12,305,500 QoQ
Shares Held
174,812
+4.7% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#121
of 1,742 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mitsubishi UFJ Trust & Banking Corp holds $324,055,173 across 66 Biotechnology names. VRTX ranks #1 (26.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
174,812 | $86,834,364 | |
| 2 | RPRX |
Royalty Pharma plc
|
1,307,514 | $73,312,309 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,523 | $40,856,211 | |
| 4 | INCY |
Incyte Corp
|
312,130 | $35,383,056 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
93,646 | $28,190,254 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
65,240 | $12,218,147 | |
| 7 | INSM |
INSMED Inc
|
91,077 | $9,710,629 | |
| 8 | EXEL |
Exelixis, Inc.
|
170,171 | $9,259,004 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $86,834,364 | 174,812 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $74,528,864 | 166,903 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $73,537,712 | 162,206 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $58,689,211 | 149,855 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $66,937,155 | 150,353 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $78,491,388 | 161,898 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $69,105,735 | 171,606 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $86,092,354 | 185,113 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $89,116,796 | 190,128 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $89,282,755 | 213,590 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $93,429,266 | 229,618 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $72,861,266 | 209,528 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $76,226,521 | 216,608 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $70,348,513 | 223,279 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $67,855,213 | 234,972 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $70,584,350 | 243,781 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $78,391,159 | 278,190 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $64,131,809 | 245,744 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $55,947,270 | 254,769 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $49,473,395 | 272,746 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $54,662,496 | 271,103 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $56,723,008 | 263,963 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $77,322,647 | 327,167 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $67,629,982 | 248,530 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $71,022,017 | 244,642 | Shares | Defined | 2020-09-11 | |
| 2020-03-31 | $49,992,103 | 210,095 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||